HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Uptake of radiolabelled endomorphins by experimental mammary adenocarcinoma.

AbstractBACKGROUND:
The aim of this study was to examine the accumulation of endomorphin-1 (Tyr-Pro-Trp-Phe-NH2) and endomorphin- 2 (Tyr-Pro-Phe-Phe-NH2) labelled with radioiodine in tumour-bearing C3H/Bi mice.
MATERIAL AND METHODS:
Mice C3H/Bi bearing transplantable mammary adenocarcinoma were used as animal models to study the interaction between micro-opioid receptors and endomorphin-1 and 2. The expression of the micro-opioid receptor in the tumours was confirmed by cross-linking assay and by RT- PCR technique.
RESULTS:
The endomorphins showed relatively high tumour accumulation - about 5.2% of dose/g tissue for endomorphin-1 and about 3.8% for endomorphin-2. The ratio of tumour to muscle for endomorphin-2 reached the highest value (12.7) six hours after injection. For endomorhin-1 this ratio was the highest (7.5) three hours after injection. The cross-linking assay of [125I]-labelled peptides with membranes, isolated from the mouse adenocarcinoma, followed by electrophoresis and autoradiography revealed the presence of a radioactive complex with molecular weight of about 65 kDa. This complex was detectable by polyclonal antibodies raised against the N-terminal end of a micro-opioid receptor. The expression of gene encoding micro-opioid receptor on mouse mammary adenocarcinoma was further confirmed by RT-PCR technique. The binding studies with membranes of mouse mammary adenocarcinoma cells have shown significantly higher Bmax values for endomorphin-1 and endomorphin- 2 (806 and 671, respectively) than for morphiceptin (131), a well-known specific micro-opioid receptor ligand.
CONCLUSIONS:
Endomorphin-1 and 2 have shown a high affinity to the m-opioid receptor present in mouse mammary adenocarcinoma. However, endomorphin-2 showed more promising characteristics in biodistribution studies.
AuthorsRafał Wiercioch, Marek Mirowski, Ewa Balcerczak, Ewa Byszewska, Ryszard Wierzbicki
JournalNuclear medicine review. Central & Eastern Europe (Nucl Med Rev Cent East Eur) Vol. 8 Issue 1 Pg. 1-5 ( 2005) ISSN: 1506-9680 [Print] Poland
PMID15977139 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cross-Linking Reagents
  • Iodine Radioisotopes
  • Ligands
  • Oligopeptides
  • Peptides
  • Receptors, Opioid, mu
  • endomorphin 1
  • endomorphin 2
Topics
  • Adenocarcinoma (pathology)
  • Animals
  • Autoradiography
  • Cell Membrane (metabolism)
  • Cross-Linking Reagents (pharmacology)
  • Female
  • Iodine Radioisotopes (pharmacokinetics)
  • Kinetics
  • Ligands
  • Mammary Neoplasms, Experimental (pathology)
  • Mice
  • Mice, Inbred C3H
  • Neoplasm Transplantation
  • Oligopeptides (pharmacokinetics)
  • Peptides (chemistry)
  • Protein Binding
  • Receptors, Opioid, mu (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: